Your browser doesn't support javascript.
loading
Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients.
Burgess-Hull, Albert J; Smith, Kirsten E; Schriefer, Destiny; Panlilio, Leigh V; Epstein, David H; Preston, Kenzie L.
Affiliation
  • Burgess-Hull AJ; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA. Electronic address: albert.burgess-hull@nih.gov.
  • Smith KE; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
  • Schriefer D; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
  • Panlilio LV; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
  • Epstein DH; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
  • Preston KL; National Institute on Drug Abuse Intramural Research Program, 251 Bayview Blvd., Baltimore, MD, 21224, USA.
Drug Alcohol Depend ; 226: 108884, 2021 09 01.
Article in En | MEDLINE | ID: mdl-34229153
ABSTRACT

BACKGROUND:

We previously showed, in people starting treatment for opioid use disorder (OUD), that stress is neither necessary nor sufficient for lapses to drug use to occur, despite an association between the two. Both theoretical clarity and case-by-case prediction accuracy may require initial differentiation among patients.

AIM:

To examine (a) evidence for distinct overall trajectories of momentary stress during OUD treatment, (b) relationships between stress trajectory and treatment response, and (c) relationships between stress trajectory and momentary changes in stress and craving prior to lapses.

METHODS:

We used ecological momentary assessment (EMA) to collect ratings of stress and craving 3x/day for up to 16 weeks in 211 outpatients during agonist treatment for OUD. With growth mixture models, we identified trajectories of stress. We used mixed effect models to examine trajectory-group differences in the dynamics of stress and craving just before lapses to any drug use.

RESULTS:

We identified four trajectories of stress Increasing (13.7 %); Moderate and Stable (23.7 %); Declining and Increasing (18 %); and Low (44.6 %). Overall drug use and opioid craving were lowest in the Low Stress group. Overall drug use was highest in the Moderate and Stable group. Alcohol use and opioid craving were highest in the Increasing Stress group. Opioid craving increased before lapse for most groups, but stress increased before lapses for only the Moderate and Stable group.

CONCLUSION:

There are natural groupings of participants with distinct patterns of stress severity during OUD treatment. Momentary stress/craving/lapse associations may be better characterized when these groupings are considered first.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Opioid / Opioid-Related Disorders Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Opioid / Opioid-Related Disorders Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Drug Alcohol Depend Year: 2021 Document type: Article